Human herpesvirus 6 (HHV-6) disease in the setting of transplantation

Current Opinion in Infectious Diseases

Volumn 25, Issue 4, 2012, Pages 438-444

  Zerr, Danielle M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

hematopoietic cell transplantation; HHV 6; solid organ transplantation; transplantation

Indexed keywords

CIDOFOVIR; FOSCARNET; GANCICLOVIR; INTERLEUKIN 6; MESSENGER RNA; VIRUS ANTIGEN; VIRUS DNA;

ANTIVIRAL ACTIVITY; ANTIVIRAL THERAPY; BLOOD SAMPLING; CHROMOSOME POSITIONING; CORD BLOOD STEM CELL TRANSPLANTATION; FLUORESCENCE IN SITU HYBRIDIZATION; GRAFT RECIPIENT; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 6 INFECTION; INFECTION PREVENTION; KIDNEY TRANSPLANTATION; NONHUMAN; PATHOGENESIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TRANSPLANTATION; VIRUS DETECTION; VIRUS ENCEPHALITIS; VIRUS REACTIVATION; VIRUS TRANSMISSION;

ANTIVIRAL AGENTS; HERPESVIRUS 6, HUMAN; HUMANS; ORGAN TRANSPLANTATION; ROSEOLOVIRUS INFECTIONS; STEM CELL TRANSPLANTATION;

EID: 84863721125     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e3283553362     Document Type: Review

References (76)

1. Ljungman P, Wang FZ, Clark DA, et al. High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients. Br J Haematol 2000; 111:774-781. (Pubitemid 32098914)
2. Yoshikawa T, Asano Y, Ihira M, et al. Human herpesvirus 6 viremia in bone marrow transplant recipients: clinical features and risk factors. J Infect Dis 2002; 185:847-853. (Pubitemid 34274426)
3. Zerr DM, Corey L, Kim HW, et al. Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. Clin Infect Dis 2005; 40:932-940. (Pubitemid 40418297)
4. Hentrich M, Oruzio D, Jager G, et al. Impact of human herpesvirus-6 after haematopoietic stem cell transplantation. Br J Haematol 2005; 128:66-72.
5. Griffiths PD, Ait-Khaled M, Bearcroft CP, et al. Human herpesviruses 6 and 7 as potential pathogens after liver transplant: prospective comparison with the effect of cytomegalovirus. J Med Virol 1999; 59:496-501. (Pubitemid 29523149)
6. Humar A, Malkan G, Moussa G, et al. Human herpesvirus-6 is associated with cytomegalovirus reactivation in liver transplant recipients. J Infect Dis 2000; 181:1450-1453. (Pubitemid 30252553)
7. Yoshikawa T, Ihira M, Suzuki K, et al. Human herpesvirus 6 infection after living related liver transplantation. J Med Virol 2000; 62:52-59.
8. Mendez JC, Dockrell DH, Espy MJ, et al. Human beta-herpesvirus interactions in solid organ transplant recipients. J Infect Dis 2001; 183:179-184. (Pubitemid 32066016)
9. Reddy S, Manna P. Quantitative detection and differentiation of human herpesvirus 6 subtypes in bone marrow transplant patients by using a single real-time polymerase chain reaction assay. Biol Blood Marrow Transplant 2005; 11:530-541. (Pubitemid 40862450)
10. Wang LR, Dong LJ, Zhang MJ, Lu DP. The impact of human herpesvirus 6B reactivation on early complications following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2006; 12:1031-1037.
11. Feldstein AE, Razonable RR, Boyce TG, et al. Prevalence and clinical significance of human herpesviruses 6 and 7 active infection in pediatric liver transplant patients. Pediatr Transplant 2003; 7:125-129. (Pubitemid 36514068)
12. Wainwright MS, Martin PL, Morse RP, et al. Human herpesvirus 6 limbic encephalitis after stem cell transplantation. Ann Neurol 2001; 50:612-619. (Pubitemid 33021919)
13. Zerr DM,Gupta D, Huang ML, et al. Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34:309-317.
14. Zerr DM. Human herpesvirus 6 and central nervous system disease in hematopoietic cell transplantation. J Clin Virol 2006; 37 (Suppl. 1):S52-S56.
15. Fotheringham J, Akhyani N, Vortmeyer A, et al. Detection of active human herpesvirus-6 infection in the brain: correlation with polymerase chain reaction detection in cerebrospinal fluid. J Infect Dis 2007; 195:450-454. (Pubitemid 46146124)
16. Seeley WW, Marty FM, Holmes TM, et al. Posttransplant acute limbic encephalitis: clinical features and relationship to HHV6. Neurology 2007; 69:156-165. (Pubitemid 47051720)
17. Tormo N, Solano C, de la Camara R, et al. An assessment of the effect of human herpesvirus-6 replication on active cytomegalovirus infection after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2010; 16:653-661.
18. Wang FZ, Larsson K, Linde A, Ljungman P. Human herpesvirus 6 infection and cytomegalovirus-specific lymphoproliferative responses in allogeneic stem cell transplant recipients. Bone Marrow Transplant 2002; 30:521-526. (Pubitemid 35331719)
19. De Pagter PJ, Schuurman R, Visscher H, et al. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome. Biol Blood Marrow Transplant 2008; 14:831-839. (Pubitemid 351773160)
20. Wang LR, Dong LJ, Zhang MJ, Lu DP. Correlations of human herpesvirus 6B and CMV infection with acute GVHD in recipients of allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant 2008; 42:673-677.
21. Savolainen H, Lautenschlager I, Piiparinen H, et al. Human herpesvirus-6 and-7 in pediatric stem cell transplantation. Pediatr Blood Cancer 2005; 45:820-825. (Pubitemid 41416493)
22. Vinnard C, Barton T, Jerud E, Blumberg E. A report of human herpesvirus 6-associated encephalitis in a solid organ transplant recipient and a review of previously published cases. Liver Transpl 2009; 15:1242-1246.
23. Nash PJ, Avery RK, Tang WH, et al. Encephalitis owing to human herpesvirus-6 after cardiac transplant. Am J Transplant 2004; 4:1200-1203. (Pubitemid 38868616)
24. Paterson DL, Singh N, Gayowski T, et al. Encephalopathy associated with human herpesvirus 6 in a liver transplant recipient. Liver Transpl Surg 1999; 5:454-455. (Pubitemid 29437024)
25. Wang FZ, Linde A, Hagglund H, et al. Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: does it have clinical significance? Clin Infect Dis 1999; 28:562-568. (Pubitemid 29242534)
26. Ogata M, Kikuchi H, Satou T, et al. Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: incidence and clinical significance. J Infect Dis 2006; 193:68-79. (Pubitemid 43032501)
27. Zerr DM, Fann JR, Breiger D, et al. HHV-6 reactivation and its effect on delirium and cognitive functioning in hematopoietic cell transplantation recipients. Blood 2011; 117:5243-5249.
28. Muta T, Fukuda T, Harada M. Human herpesvirus-6 encephalitis in hematopoietic SCT recipients in Japan: a retrospective multicenter study. Bone Marrow Transplant 2009; 43:583-585.
29. Sakai R, Kanamori H, Motohashi K, et al. Long-term outcome of human herpesvirus-6 encephalitis after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2011; 17:1389-1394.
30. Lautenschlager I, Linnavuori K, Lappalainen M, et al. HHV-6 reactivation is often associated with CMV infection in liver transplant patients. Transpl Int 2000; 13 (Suppl. 1):S351-S353.
31. Razonable RR, Brown RA, Humar A, et al. Herpesvirus infections in solid organ transplant patients at high risk of primary cytomegalovirus disease. J Infect Dis 2005; 192:1331-1339. (Pubitemid 41401145)
32. Guardia AC, Stucchi RS, Sampaio AM, et al. Human herpesvirus 6 in donor biopsies associated with the incidence of clinical cytomegalovirus disease and hepatitis C virus recurrence. Int J Infect Dis 2012; 16:e124-e129.
33. Cone RW, Hackman RC, Huang ML, et al. Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation. N Engl J Med 1993; 329:156-161. (Pubitemid 23195735)
34. Buchbinder S, Elmaagacli AH, Schaefer UW, Roggendorf M. Human herpesvirus 6 is an important pathogen in infectious lung disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 2000; 26:639-644.
35. Singh N, Carrigan DR, Gayowski T, Marino IR. Human herpesvirus-6 infection in liver transplant recipients: documentation of pathogenicity. Transplantation 1997; 64:674-678. (Pubitemid 27407091)
36. Costa C, Curtoni A, Bergallo M, et al. Quantitative detection of HHV-6 and HHV-7 in transbronchial biopsies from lung transplant recipients. New Microbiol 2011; 34:275-280.
37. Hall CB, Caserta MT, Schnabel KC, et al. Congenital infections with human herpesvirus 6 (HHV6) and human herpesvirus 7 (HHV7). J Pediatr 2004; 145:472-477. (Pubitemid 39345982)
38. Hall CB, Caserta MT, Schnabel K, et al. Chromosomal integration of human herpesvirus 6 is the major mode of congenital human herpesvirus 6 infection. Pediatrics 2008; 122:513-520.
39. Tanaka-Taya K, Sashihara J, Kurahashi H, et al. Human herpesvirus 6 (HHV-6) is transmitted from parent to child in an integrated form and characterization of cases with chromosomally integrated HHV-6 DNA. J Med Virol 2004; 73:465-473. (Pubitemid 38685755)
40. Leong HN, Tuke PW, Tedder RS, et al. The prevalence of chromosomally integrated human herpesvirus 6 genomes in the blood of UK blood donors. J Med Virol 2007; 79:45-51. (Pubitemid 44902053)
41. Clark DA, Nacheva EP, Leong HN, et al. Transmission of integrated human herpesvirus 6 through stem cell transplantation: implications for laboratory diagnosis. J Infect Dis 2006; 193:912-916.
42. Kamble RT, Clark DA, Leong HN, et al. Transmission of integrated human herpesvirus-6 in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2007; 40:563-566. (Pubitemid 47382127)
43. Jeulin H, Guery M, Clement L, et al. Chromosomally integrated HHV-6: slow decrease of HHV-6 viral load after hematopoietic stem-cell transplantation. Transplantation 2009; 88:1142-1143.
44. Potenza L, Barozzi P, Masetti M, et al. Prevalence of human herpesvirus-6 chromosomal integration (CIHHV-6) in Italian solid organ and allogeneic stem cell transplant patients. Am J Transplant 2009; 9:1690-1697.
45. Lee SO, Brown RA, Razonable RR. Clinical significance of pretransplant chromosomally integrated human herpesvirus-6 in liver transplant recipients. Transplantation 2011; 92:224-229.
46. Potenza L, Barozzi P, Rossi G, et al. May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? Transplantation 2011; 92:e49-e51; author reply e-2.
47. Kobayashi D, Kogawa K, Imai K, et al. Quantitation of human herpesvirus-6 (HHV-6) DNA in a cord blood transplant recipient with chromosomal integration of HHV-6. Transpl Infect Dis 2011; 13:650-653.
48. Lusso P. HHV-6 and the immune system: mechanisms of immunomodulation and viral escape. J Clin Virol 2006; 37 (Suppl. 1):S4-S10.
49. Ogata M, Satou T, Kawano R, et al. Correlations of HHV-6 viral load and plasma IL-6 concentration with HHV-6 encephalitis in allogeneic stem cell transplant recipients. Bone Marrow Transplant 2010; 45:129-136.
50. Drobyski WR, Knox KK, Majewski D, Carrigan DR. Brief report: fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrowtransplant recipient. N Engl J Med 1994; 330:1356-1360. (Pubitemid 24136059)
51. De Almeida Rodrigues G, Nagendra S, Lee CK, De Magalhaes-Silverman M. Human herpes virus 6 fatal encephalitis in a bone marrow recipient. Scand J Infect Dis 1999; 31:313-315. (Pubitemid 29389243)
52. Shintaku M, Kaneda D, Tada K, et al. Human herpes virus 6 encephalomyelitis after bone marrow transplantation: report of an autopsy case. Neuropathology 2010; 30:50-55.
53. Huang LM, Kuo PF, Lee CY, et al. Detection of human herpesvirus-6 DNA by polymerase chain reaction in serum or plasma. J Med Virol 1992; 38:7-10.
54. Boutolleau D, Fernandez C, Andre E, et al. Human herpesvirus (HHV)-6 and HHV-7: two closely related viruses with different infection profiles in stem cell transplantation recipients. J Infect Dis 2003; 187:179-186. (Pubitemid 36132631)
55. Kondo K, Kondo T, Okuno T, et al. Latent human herpesvirus 6 infection of human monocytes/macrophages. J Gen Virol 1991; 72 (Pt 6):1401-1408.
56. Norton RA, Caserta MT, Hall CB, et al. Detection of human herpesvirus 6 by reverse transcription-PCR. J Clin Microbiol 1999; 37:3672-3675. (Pubitemid 29491112)
57. Razonable RR, Fanning C, Brown RA, et al. Selective reactivation of human herpesvirus 6 variant A occurs in critically ill immunocompetent hosts. J Infect Dis 2002; 185:110-113. (Pubitemid 34043024)
58. Boutolleau D, Duros C, Bonnafous P, et al. Identification of human herpesvirus 6 variants A and B by primer-specific real-time PCR may help to revisit their respective role in pathology. J Clin Virol 2006; 35:257-263. (Pubitemid 43188970)
59. Volin L, Lautenschlager I, Juvonen E, et al. Human herpesvirus 6 antigenaemia in allogeneic stem cell transplant recipients: impact on clinical course and association with other beta-herpesviruses. Br J Haematol 2004; 126:690-696. (Pubitemid 39221305)
60. Sampaio AM, Thomasini RL, Guardia AC, et al. Cytomegalovirus, human herpesvirus-6, and human herpesvirus-7 in adult liver transplant recipients: diagnosis based on antigenemia. Transplant Proc 2011; 43:1357-1359.
61. Hall CB, Caserta MT, Schnabel KC, et al. Persistence of human herpesvirus 6 according to site and variant: possible greater neurotropism of variant A. Clin Infect Dis 1998; 26:132-137. (Pubitemid 28068166)
62. Troy SB, Blackburn BG, Yeom K, et al. Severe encephalomyelitis in an immunocompetent adult with chromosomally integrated human herpesvirus 6 and clinical response to treatment with foscarnet plus ganciclovir. Clin Infect Dis 2008; 47:e93-e96.
63. Daibata M, Taguchi T, Nemoto Y, et al. Inheritance of chromosomally integrated human herpesvirus 6 DNA. Blood 1999; 94:1545-1549. (Pubitemid 29411303)
64. Ward KN, Leong HN, Nacheva EP, et al. Human herpesvirus 6 chromosomal integration in immunocompetent patients results in high levels of viral DNA in blood, sera, and hair follicles. J Clin Microbiol 2006; 44:1571-1574.
65. Jeulin H, Salmon A, Gautheret-Dejean A, et al. Contribution of human herpesvirus 6 (HHV-6) viral load in whole blood and serum to investigate integrated HHV-6 transmission after haematopoietic stem cell transplantation. J Clin Virol 2009; 45:43-46.
66. De Bolle L, Naesens L, De Clercq E. Update on human herpesvirus 6 biology, clinical features, and therapy. Clin Microbiol Rev 2005; 18:217-245. (Pubitemid 40170670)
67. Galarraga MC, Gomez E, de Ona M, et al. Influence of ganciclovir prophylaxis on cytomegalovirus, human herpesvirus 6, and human herpesvirus 7 viremia in renal transplant recipients. Transplant Proc 2005; 37:2124-2126. (Pubitemid 40956391)
68. Rapaport D, Engelhard D, Tagger G, et al. Antiviral prophylaxis may prevent human herpesvirus-6 reactivation in bone marrow transplant recipients. Transpl Infect Dis 2002; 4:10-16. (Pubitemid 34786820)
69. Tokimasa S, Hara J, Osugi Y, et al. Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation. Bone Marrow Transplant 2002; 29:595-598. (Pubitemid 34537720)
70. Cheng FW, Lee V, Leung WK, et al. HHV-6 encephalitis in pediatric unrelated umbilical cord transplantation: a role for ganciclovir prophylaxis? Pediatr Transplant 2010; 14:483-487.
71. Ishiyama K, Katagiri T, Hoshino T, et al. Preemptive therapy of human herpesvirus-6 encephalitis with foscarnet sodium for high-risk patients after hematopoietic SCT. Bone Marrow Transplant 2011; 46:863-869.
72. Ogata M, Satou T, Kawano R, et al. Plasma HHV-6 viral load-guided preemptive therapy against HHV-6 encephalopathy after allogeneic stem cell transplantation: a prospective evaluation. Bone Marrow Transplant 2008; 41:279-285. (Pubitemid 351260383)
73. Ishiyama K, Katagiri T, Ohata K, et al. Safety of preengraftment prophylactic foscarnet administration after allogeneic stem cell transplantation. Transpl Infect Dis 2012; 14:33-39.
74. Tunkel AR, Glaser CA, Bloch KC, et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2008; 47:303-327. (Pubitemid 352013512)
75. Tomblyn M, Chiller T, Einsele H, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 2009; 15:1143-1238.
76. Dewhurst S.Human herpesvirus type 6 andhuman herpesvirus type7 infections of the central nervous system. Herpes 2004; 11 (Suppl. 2):105A-111A.